glp-1 news updates november 2025 Retailers across the country are noticing a spike in returns of clothing as more Americans embrace drugs for weight loss. The rate of retail exchanges where shoppers traded clothing for a Pfizer GLP-1 weight loss drug

This blend allows researchers to study the co-activation of two distinct nutrient-response systems

From retail to food service, Ozempic is disrupting industries as more Americans turn to GLP-1 drugs for weight loss

Mounjaro (tirzepatide): Manufactured by Eli Lilly and FDA-approved for type 2 diabetes, Mounjaro targets both GLP-1 and GIP receptors and has been widely prescribed off-label for weight loss

Later, it was approved for use in individuals with a body mass index (BMI) of 27 or above weight gain and those with at least one weight-related health problem, such as high blood pressure or type 2 diabetes, to promote weight loss